Clinical Trials Logo

Gram-Negative Pneumonia clinical trials

View clinical trials related to Gram-Negative Pneumonia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04208945 Recruiting - Clinical trials for Pneumonia, Ventilator-associated

Nebulized Colistin for Gram Negative VAP Prevention.

VAPICO
Start date: December 2019
Phase: N/A
Study type: Interventional

Colistin is used as an elective treatment of infections of multi drug resistant gram negative bacteria. Until now colistin is used in the therapeutic regimen of these infections intravenous or nebulized. There are a plenty of studies about the efficacy of nebulized colistin in the therapy of pseudomonas aeruginosa pneumonia in patients with cystic fibrosis and in the therapy of ventilator associated pneumonia in ICU. On the other hand there are only a few studies about the use of nebulized colistin in the prevention of ventilator associated pneumonia whereas the role of nebulized colistin in the prevention of severe forms of pneumonia such as VAP due to multi drug resistant gram negative bacteria are limited. This double blinded randomized trial aim to investigate the effect of nebulized colistin on the incidence of patients with due to gram negative bacteria in the ICU compared to nebulized normal saline.